FDA Inspection 971476 — Servy Institute For Reproductive Endocrinology
The FDA completed an inspection of Servy Institute For Reproductive Endocrinology on May 26, 2016 in Augusta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 26, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Augusta, GA (United States)